170 related articles for article (PubMed ID: 9833617)
1. The management of high-risk gestational trophoblastic tumours (GTT).
Newlands ES; Bower M; Holden L; Short D; Brock C; Rustin GJ; Begent RH; Bagshawe KD
Int J Gynaecol Obstet; 1998 Apr; 60 Suppl 1():S65-70. PubMed ID: 9833617
[TBL] [Abstract][Full Text] [Related]
2. EMA/CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 patients.
Bower M; Newlands ES; Holden L; Short D; Brock C; Rustin GJ; Begent RH; Bagshawe KD
J Clin Oncol; 1997 Jul; 15(7):2636-43. PubMed ID: 9215835
[TBL] [Abstract][Full Text] [Related]
3. The management of high-risk gestational trophoblastic tumours (GTT).
Newlands ES; Bower M; Holden L; Short D; Brock C; Rustin GJS; Begent RHJ; Bagshawe KD
Int J Gynaecol Obstet; 1998 Apr; 60 Suppl 1():S65-S70. PubMed ID: 29645230
[TBL] [Abstract][Full Text] [Related]
4. Management of resistant gestational trophoblastic tumors.
Newlands ES; Bower M; Holden L; Short D; Seckl MJ; Rustin GJ; Begent RH; Bagshawe KD
J Reprod Med; 1998 Feb; 43(2):111-8. PubMed ID: 9513872
[TBL] [Abstract][Full Text] [Related]
5. Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors.
Newlands ES; Mulholland PJ; Holden L; Seckl MJ; Rustin GJ
J Clin Oncol; 2000 Feb; 18(4):854-9. PubMed ID: 10673528
[TBL] [Abstract][Full Text] [Related]
6. Effects of multiagent chemotherapy and independent risk factors in the treatment of high-risk GTT--25 years experiences of KRI-TRD.
Kim SJ; Bae SN; Kim JH; Kim CT; Han KT; Lee JM; Jung JK
Int J Gynaecol Obstet; 1998 Apr; 60 Suppl 1():S85-96. PubMed ID: 9833620
[TBL] [Abstract][Full Text] [Related]
7. Results with the EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) regimen in high risk gestational trophoblastic tumours, 1979 to 1989.
Newlands ES; Bagshawe KD; Begent RH; Rustin GJ; Holden L
Br J Obstet Gynaecol; 1991 Jun; 98(6):550-7. PubMed ID: 1651757
[TBL] [Abstract][Full Text] [Related]
8. Primary treatment of metastatic high-risk gestational trophoblastic neoplasia with EMA-CO chemotherapy.
Lurain JR; Singh DK; Schink JC
J Reprod Med; 2006 Oct; 51(10):767-72. PubMed ID: 17086804
[TBL] [Abstract][Full Text] [Related]
9. Alternating weekly chemotherapy with etoposide-methotrexate-dactinomycin/cyclophosphamide-vincristine for high-risk gestational trophoblastic disease.
Soper JT; Evans AC; Clarke-Pearson DL; Berchuck A; Rodriguez G; Hammond CB
Obstet Gynecol; 1994 Jan; 83(1):113-7. PubMed ID: 8272290
[TBL] [Abstract][Full Text] [Related]
10. EMA/CO regimen in high-risk gestational trophoblastic tumor (GTT).
Bolis G; Bonazzi C; Landoni F; Mangili G; Vergadoro F; Zanaboni F; Mangioni C
Gynecol Oncol; 1988 Nov; 31(3):439-44. PubMed ID: 2846414
[TBL] [Abstract][Full Text] [Related]
11. Plasma methotrexate levels in patients receiving etoposide, methotrexate, actinomycin, cyclophosphamide, and vincristine (EMA-CO) chemotherapy for trophoblastic neoplasia.
Kohorn EI
Gynecol Oncol; 1993 Sep; 50(3):300-4. PubMed ID: 8406191
[TBL] [Abstract][Full Text] [Related]
12. Placental site trophoblastic tumor: an overview.
Bonazzi C; Urso M; Dell'Anna T; Sacco S; Buda A; Cantú MG
J Reprod Med; 2004 Aug; 49(8):585-8. PubMed ID: 15457847
[TBL] [Abstract][Full Text] [Related]
13. Low-risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000.
McNeish IA; Strickland S; Holden L; Rustin GJ; Foskett M; Seckl MJ; Newlands ES
J Clin Oncol; 2002 Apr; 20(7):1838-44. PubMed ID: 11919242
[TBL] [Abstract][Full Text] [Related]
14. Etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine for the treatment of metastatic, high-risk gestational trophoblastic disease.
Schink JC; Singh DK; Rademaker AW; Miller DS; Lurain JR
Obstet Gynecol; 1992 Nov; 80(5):817-20. PubMed ID: 1328977
[TBL] [Abstract][Full Text] [Related]
15. [EMA/CO regimen for chemotherapy 24 patients with ultra high-risk gestational trophoblastic neoplasia].
Shen T; Chen LL; Qin JL; Wang XY; Cheng XD; Xie X; Lyu WG
Zhonghua Fu Chan Ke Za Zhi; 2018 Jun; 53(6):371-376. PubMed ID: 29961278
[No Abstract] [Full Text] [Related]
16. Management of drug resistant gestational trophoblastic neoplasia.
Patel SM; Desai A
J Reprod Med; 2010; 55(7-8):296-300. PubMed ID: 20795341
[TBL] [Abstract][Full Text] [Related]
17. Relapsed or refractory gestational trophoblastic neoplasia treated with the etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EP-EMA) regimen.
Mao Y; Wan X; Lv W; Xie X
Int J Gynaecol Obstet; 2007 Jul; 98(1):44-7. PubMed ID: 17481633
[TBL] [Abstract][Full Text] [Related]
18. Management of high-risk gestational trophoblastic neoplasia with etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine chemotherapy.
Cyriac S; Rajendranath R; Sridevi V; Sagar TG
J Reprod Med; 2011; 56(5-6):219-23. PubMed ID: 21682117
[TBL] [Abstract][Full Text] [Related]
19. High-risk gestational trophoblastic neoplasia at Gujarat Cancer and Research Institute: thirteen years of experience.
Chauhan A; Dave K; Desai A; Mankad M; Patel S; Dave P
J Reprod Med; 2010; 55(7-8):333-40. PubMed ID: 20795348
[TBL] [Abstract][Full Text] [Related]
20. The management of gestational trophoblastic tumors with etoposide, methotrexate, and actinomycin D.
Soto-Wright V; Goldstein DP; Bernstein MR; Berkowitz RS
Gynecol Oncol; 1997 Jan; 64(1):156-9. PubMed ID: 8995566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
